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1. Introduction 
In spite of advances in the quality of prenatal care, management of high-risk pregnancies 
and treatment strategies targeting prevention of preterm births, the rate of preterm births in 
the US has continued to rise over the last two decades and is associated with high mortality 
and morbidity. Care of preterm infants also poses a significant financial burden on limited 
health care resources. Infants born at less than 37 weeks gestation account for 69% of all US 
infant deaths and their care has been modestly estimated at 26 billion dollars per year 
(Behrman et al., 2006; MacDorman et al., 2008). Preterm Premature Rupture of Membranes 
(PPROM) causes 30 - 40% of all preterm births and is disproportionately distributed such 
that African Americans suffer twice the rate of PPROM than Caucasians (Goldenberg et al., 
1996a). Although some limited success has been achieved in the treatment of iatrogenic fetal 
membrane (FM) rupture resulting from amniocentesis or fetal surgery (Quintero et al., 1999; 
Young et al., 2000; O’Brien et al., 2001; Bilic et al., 2010), there has been no success in the 
repair of spontaneously ruptured FM, as occurs with PPROM (Quintero et al., 1998; 
Sciscione et al., 2001; Young et al., 2004b; Devlieger et al., 2006). Recent progress in the 
understanding of the biochemically-mediated processes which lead to FM weakening and 
rupture suggests that inhibition of these processes may be possible. This generates hope that 
many cases of PPROM may ultimately be preventable (R.M. Moore et al., 2009b, 2010; 
Kumar et al., 2011).  
2. New techniques used in the studies on FM rupture 
2.1 Mapping procedure 
We have developed and utilized a systematic procedure to map the rupture strength of FM 
over its entire topographic surface, thereby identifying relatively weak areas for further 
biochemical, proteomic, and sophisticated biomechanical testing.  
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Fig. 1. Fetal Membrane cutting procedure. (Top Left) Marked membranes showing location 
of primary cuts required to lay the membranes flat. (Top Right) Membrane fragments 
removed with outlines of pieces on lab table paper. (Bottom) Paper tracing reproduction 
showing cuts, orientation and location of all pieces, and strength results. (Reproduced with 
permission from El-Khwad et al. Biol Reprod 72:720-726, 2005.) 
Although animal data document homogeneous weakening of the FM over the entire surface 
with increasing gestation (Lei et al., 1995, 1997; Paavola et al., 1995; Parry et al., 1998), 
attempts to demonstrate similar gestational changes in human FM were unsuccessful 
(Manabe et al., 1991). Studies in which whole FM or randomly selected pieces were sampled 
showed high variability and no definite pattern of remodeling and apoptosis. In response to 
the challenge of interpreting variable data, we developed a systematic method of cutting the 
membranes (El-Khwad et al., 2005; Fig. 1.). Fetal membranes to be tested were cut along 
specific grids. We identified the region of the membranes overlying the cervix by marking it 
in utero with Gentian Violet. As a result, the exact location and orientation of each piece cut 
from the membranes relative to both the placental disc and to the region that formerly 
overlay the cervix was determined. A paper model (tracing) mapping the location and the 
rupture strength data of each piece is ultimately constructed. This two dimensional map can 
be folded to show the original three-dimensional physical configuration of the amniotic sac 
with superimposed Rupture Strength results. This approach confirmed an inherent 
inhomogeneity in the biomechanics of the gestational sac and clearly demonstrated the 
para-cervical weak zone. These features had been camouflaged in many previous studies 
where parts of weak and strong regions were tested together with the assumption of FM 
homogeneity over its entire surface.  
2.2 Rupture test equipment 
Specialized equipment is necessary to determine FM physical properties. Our testing 
apparatus, developed in collaboration with Com-Ten industries (a national supplier of 
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tensile testing equipment) (Moore et al., 2006), has a number of advantages over that used in 
previous biomechanical studies of FM: 1. It applies a bi-axial (two dimensional) stretch on 
the membranes similar to normal physiology; 2. It uses the puncture mode with any size 
probe and tissue clamp – it is thus possible to perform a detailed survey of physical 
properties over the entire fetal membrane surface in a reasonable time period;  3. It will hold 
preset displacements or forces for viscoelastic studies; 4. Probes may be fit with ultrasound 
sensors for simultaneous measurement of membrane thickness; 5. High precision - 
calibrated accuracy is 0.05 Newton force and 0.01 cm displacement over appropriate 
intervals; 6. Tissue specimens are kept moist at all times. 7. Data is captured in digital form, 
displayed graphically, and analyzed by the software. A force-displacement curve (Fig. 2.) is 
computer generated during each experiment and the strength characteristics (membrane 
Rupture Strength, Work to Rupture, Stiffness and other physical properties) are derived and 
calculated from the data. Data is also exportable for independent analysis.  
 
 
Fig. 2. Strength testing equipment. (Top Left) Close-up view of fetal membrane holding 
apparatus (from top to bottom – load cell force sensor, rupture probe with spherical tip, 
membrane holding assembly). (Top Right) Com-Ten Ball-Burst Compression Testing 
Equipment (from left to right – computer controller, analog-digital converter, membrane 
rupture assembly). (Bottom) Typical force displacement curve. (Reproduced with 
permission from El-Khwad et al. Biol Reprod 72:720-726, 2005.) 
Development of rupture test equipment and use of this mapping methodology helped us 
establish the following: 
2.2.1. Both term and preterm FM are biomechanically and biochemically heterogeneous over 
their surfaces. Only by use of this mapping procedure and equipment have we been able to 
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identify and topologically map weak areas so that characterization can lead to direct 
investigation of the mechanism of weakening (El-Khwad et al., 2005, 2006; Rangaswamy et 
al., 2011). 
2.2.2. Sequence of FM rupture – amnion and choriodecidua first stretch together followed by 
their separation, then choriodecidua ruptures prior to reaching its elastic limit and amnion 
stretches further in a non-elastic fashion, then ruptures (Arikat et al., 2006). 
2.2.3. FM strain hardens with acute cyclical stretch. Like metal pulled into wire it becomes 
stronger and less elastic. It does not weaken (Pandey et al., 2007). 
2.2.4. Determine which physiological agents or processes cause sufficient FM weakening to 
precipitate rupture, and under what conditions (dose, duration, etc.) this occurs.  
2.3 Equipment to measure adhesion of amnion to choriodecidua 
Discovery that FM (amnion and choriodecidua) separate during the process of rupture led 
to development of equipment to measure their adherence and allowed us demonstrate that 
FM peel apart and become less adherent with increasing gestation (Kumar et al., 2009; Strohl 
et al., 2010). Commercial industrial tensile testing equipment (Com-Ten) was adapted to 
perform a standard engineering T-peel test to measure the adhesive force of FM (Fig. 3.). Use 
of this equipment allowed us to determine that FM components become less adherent and 
separate with increasing gestational age (Strohl et al., 2010). 
 
 
Fig. 3. Peel testing procedures. Tissue samples are cut out from FM kept moist and laid flat 
and kept moist (A). Stiff filter paper stints assist in holding and mounting the partially 
manually peeled amnion and choriodecidua by maintaining shape (B). Membrane piece 
mounted on custom clamps which are maintained in fixed position by a plexiglass mount 
support to assist sample loading (C). Sample loaded clamps with supporting Plexiglas 
mount as a single unit attached to the peel testing device (D). The peel tester with the FM 
piece loaded and the plexiglass mount support removed before beginning the test (E). FM 
components, amnion and choriodecidua, being peeled apart between the clamp jaws (F).  
3. Para-cervical weak zone in FM – A result of programmed biochemical 
weakening processes 
Rupture of FM (ROM) is an integral event in the onset and development of labor. Even 
though ROM usually follows uterine contractions, it precedes the onset of contractions in at 
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least 10% of term labor and 40% of premature labor. This implies that the stretch force alone 
is not the cause of FM weakening.  
3.1 Term FM develops a para-cervical “weak zone” where rupture initiates 
Rat model studies suggest that amnion, the strongest component of FM undergoes collagen 
remodelling as gestation progresses (Paavola et al., 1995; Lockwood et al., 1999). As a result 
of these phenomena, FM is postulated to weaken and become more susceptible to rupture 
near the end of gestation. Apoptosis has also been suggested to occur near term in human 
amnion and chorion (McLaren et al., 2000a). Malak and Bell first identified an area of so-
called “high morphological change” in the zone of FM overlying the cervix (Malak & Bell, 
1994). This distinct para-cervical region has been demonstrated in the FM from both term 
vaginal and caesarean section deliveries without labor and comprises approximately 2-10% 
of the total FM surface area (McLaren et al., 1999a; McParland et al., 2003). Bell’s group 
further characterized this area of FM as having increased matrix metalloproteinase  
(MMP) -9, increased trophoblast apoptosis, differences in the thickness of membrane sub 
layers, and increased myofibroblasts in this area (McLaren et al., 1999b, 2000a, 2000b; 
McParland et al., 2003). Lappas and colleagues have confirmed an increase in apoptotic 
markers, and have reported increased NF-kB activity and acetylated-forkhead box O1 
protein expression in the para-cervical FM region (Reti et al., 2007; Lappas et al., 2009). All 
these studies have presumed that remodelling in this para-cervical zone leads to FM 
weakening and subsequent rupture.  
We have identified a focal “weak zone” with biochemical characteristics equivalent to the 
previously described “zone of high morphological change” in the para-cervical region of 
FM. Using FM from repeat cesarean section performed prior to any labor, we showed that 
this region ruptures with only 20 - 50% of the force required to rupture other areas of the FM 
(Fig. 4.), and that it exhibits a biochemical signature of increased collagen remodeling and 
apoptosis (El-Khwad et al., 2005). Western Blot analysis indicated increases in matrix 
metalloproteinase 9 (MMP-9) and cleaved PARP, and decreases in fibulins 1, 3, 5 and TIMP-
3 in the Weak Zone. MMP-2 did not show differences. TIMP-1 was barely detectable; TIMP-
2 and TIMP-4 protein were detectable in all specimens but did not change with Strength. 
Other groups have also confirmed the increase in markers of collagen remodeling and 
apoptosis (Malak & Bell et al., 1994; El-Khwad et al., 2005, 2006; Meinert et al., 2007, Reti et 
al., 2007; Han et al., 2008; Lappas et al, 2008, 2009, 2010a, 2010b).  
Using FM from patients with AROM (artificial rupture of membranes) and SROM 
(spontaneous rupture of membranes), we have further demonstrated that the para-cervical 
weak zone persists with the same biochemical signature as that identified in pre-labor 
cesarean section membranes. As the rupture tear line usually extends through the weak 
zone, we have postulated that it contains the site of initiation of FM rupture (El-Khwad et 
al., 2005, 2006). We have also demonstrated that acute, repetitive stretch does not weaken, 
but paradoxically strengthens FM (Pandey V et al., 2007). Our studies, those of the Bell 
group, and now those of four other groups (as indicated above)  thus strongly support the 
concept of regional differences in FM properties, most specifically, that the area over the 
cervix is significantly weaker than the rest of the FM with concomitant differences in 
biochemical and histological properties. Taken together, the data indicate that term FM 
normally weakens in late gestation as a result of programmed biochemically mediated 
processes. Presumably, spontaneous FM rupture at term usually results from the mechanical 
stresses of labor upon biochemically pre-weakened membranes. 
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Fig. 4. Fetal membrane strength. [Bottom] Mean strength of cervical zones for each patient is 
less than the mean strength of the remaining areas (P < 0.001). [Top] Individual patient data 
showing a weaker cervical zone for each of the 12 patients relative to the remaining areas. 
(Reproduced with permission from El-Khwad et al. Biol Reprod 72:720-726, 2005.) 
3.2 Role of MMP activation and apoptosis in the weak zone formation 
Fortunato and Menon (2004) have extensively reviewed the roles played by MMPs and 
apoptosis in FM rupture. The strength of amnion and chorion is largely due to collagen. 
Collagens I, III, IV, V and VI have been described in various layers of amniochorion. The 
major strength in amnion is derived from collagen I (seen extensively in the compact layer 
and adjacent mesoderm) and collagen IV (a major component of the basement membrane 
and of the bundles connecting the mesenchymal layer and the epithelium) (Bachmaier et al., 
1999). Degradation of collagen is controlled by specific MMPs as modulated by tissue 
inhibitors of matrix metalloproteinases (TIMPs). Thus, the ratio of MMPs and TIMPs is a 
good indicator of collagen degradation, which along with the deposition rate of new 
collagen by fibroblasts, determines the ultimate tissue strength. Although MMP types 1, 2, 3, 
8 and 9 have been well described in amniochorion; major investigative work in FM has been 
done with MMP types 2 and 9. MMP-1 predominates prior to the onset of contractions as 
described by Bryant-Greenwood and Yamamoto. FM MMP-2 is constitutive and reportedly 
does not respond to cytokines or change with PPROM or labor (term or preterm) [Fortunato 
et al., 1999; Maymon et al., 2001; Xu et al., 2002]. In contrast, both active and latent forms of 
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MMP-9 have been shown to increase in human amniotic fluid with PPROM and in amniotic 
fluid of rhesus monkeys after inducing labor with cytokines (Bryant-Greenwood et al., 1995; 
Osmers et al., 1995; Athayde et al., 1999; Vadillo-Ortega et al., 2002). MMP-9 can also be 
induced in FM tissue with PGE2, PGF2ǂ, TNFǂ and ROS (Buhimschi et al., 2000; Sciscione et 
al., 2001; Ulug et al., 2001; Arechavaleta-Velasco et al., 2002; Zaga et al., 2004). TIMP-1, 
which controls the activity of MMP-9, has been extensively studied in FM and found to 
decrease with PROM and labor (Ulug et al., 2001; Arechavaleta-Velasco et al., 2002; 
Buhimschi et al., 2000; Zaga et al., 2004; McLaren et al., 2000b). Thus we conclude that MMP-
9 plays a major role in FM remodeling, weakening and rupture. Our work also demonstrates 
that MMP-9 levels are an excellent marker for FM strength (El-Khwad et al., 2005, 2006; 
Kumar et al., 2006; R.M. Moore et al., 2009b) [Fig. 5, 7, 8, 10]. TIMP-3 has a direct correlation 
with FM rupture strength (unlike TIMP types 1 and 2) and was significantly decreased in 
the weak zone (El-Khwad et al., 2005, 2006). Unlike other TIMPs, TIMP-3 inhibits all the 
gelatinases, TNF-ǂ, and also is stored within ECM (Mannello et al., 2001). 
MMP activation and apoptosis are often interrelated. The ECM acts a major stabilizing 
factor in many tissue systems. This stability is compromised when MMP activation leads to 
the breakdown of ECM leading to apoptosis (Boudreau et al., 1995; Chintala e al., 2002). 
MMPs may also induce apoptosis by cleaving membrane bound cytokines, including TNFǂ 
and FasL (Gearing et al., 1994; Kayagaki et al., 1995). Apoptosis can also induce activation of 
MMPs. In addition, the same agents which have been reported to cause apoptosis in FM 
tissue also activate and increase transcription of MMPs, specifically, MMP-1, MMP-9 (So  
et al., 1992; Fortunato et al., 2002). We have reported a parallel increase in prostaglandins 
with induction of apoptosis in amnion epithelial, mesenchymal and WISH cells with 
several non-physiological (actinomycin D, cycloheximide, staurosporin) and physiological 
(ceramide, lactosylceramide, PGJ2 metabolites) apoptotic agents (Moore et al., 1988, 1993). 
 
 
Fig. 5. Biochemical characteristics of fetal membrane regions: Western blot showing 
differences in MMP-9, TIMP-3 and PARP cleavage between weak, paracervical regions (C) 
and relatively strong remaining areas (R). Typical Western blot showing parallel strength 
differences in cervical (C) and remaining (R) areas of the fetal membranes from three 
patients. (Reproduced with permission from El-Khwad et al. Biol Reprod 72:720-726, 2005.) 
Prostaglandins also induce transcription and activate MMPs in most tissues (Lyons et al., 
2002; Yoshida et al., 2002). The apoptotic process, thus, potentially weakens FM by 
eliminating fibroblastic cells, which lay down new collagen, and simultaneously activates 
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enzyme systems, which break down existing collagen. Activation of MMPs feeds forward to 
increase apoptosis, which subsequently feeds back to further increase MMP activation. 
The physiological mechanisms that initiate MMP activation and apoptosis in FM are not 
understood. Many constituents of amniotic fluid whose concentrations increase with 
gestation, with infection, or even with rupture of membranes (TNFǂ, IL-1ǃ, 
lactosylceramide, etc) have been shown to cause apoptosis in cells derived from FM and 
intact membranes (Moore et al., 1988, 1993). Most of these “apoptotic” agents also increase 
transcription or activation of MMPs, especially MMP-9 (Kumar et al., 2006; R.M. Moore et 
al., 2009b; Menon et al., 2004; Zaga et al., 2004). Several groups have proposed the 
synergistic effects of MMP activation and apoptosis leading to rupture of the FM (McLaren 
et al., 2000a; Fortunato et al., 2000; Bowen et al., 2002; Lei et al., 1996). The promoter 
polymorphisms in some cytokines (TNFǂ and IL-1ǃ) and MMPs (-1,-8,-9) have been 
identified to be associated with PPROM (Ferrand et al., 2002; Fujimoto et al., 2002; 
Hernandez-Guerrero et al., 2003; Roberts et al., 1999). Patients with these polymorphisms 
may have earlier initiation of the programmed weakening process resulting in premature 
rupture of FM and earlier deliveries.  
3.3 Structural protein changes in the extracellular matrix of the “weak zone” in FM 
As part of the remodeling processes in the weak zone, there must be changes in the 
structural proteins that could contribute to the weakening of FM. Changes in MMPs and 
TIMPs on their own do not result in weakening and rupture of FM. The collagen structural 
units or other components of extracellular matrix (ECM) may undergo degradation resulting 
in weakening of FM. At least half of the published reports found no decrease in fibrillar 
collagen in the area of the rupture site in human FM, however (Manabe et al., 1991; Al-Zaid 
et al., 1980; Evaldson et al., 1987; Halaburt et al., 1989). This is in contrast to animal studies 
in which collagen degradation is the major factor in remodeling of FM (Lei et al., 1996). 
There is some evidence that other processes play a crucial role in human FM weakening: 1. 
Collagen fiber bundles are more dispersed and less well organized in the area of FM rupture 
site as demonstrated through X-ray diffraction and microscopy (Connon et al., 2007). This 
disorganization is also supported by evidence that decorin and biglycan are decreased and 
increased respectively at the site of FM rupture (Meinert et al., 2001 & 2007). Decorin is a 
protein that promotes protein fiber organization and biglycan has the opposite effect. 2. FM 
mesenchymal cells undergo “phenotypic switching” from strength promoting 
myofibroblasts to macrophages that are capable of producing cytokines which weaken the 
FM (Kim et al., 2008). 3. Numerous studies have demonstrated increased apoptotic activity 
near the site of SROM (Runic et al., 1998; Yuan et al., 2009; Sagol et al., 2002). 4. We have 
reported that three members of the fibulin protein family are decreased in the para-cervical 
weak zone (R.M. Moore et al., 2009a). These proteins are involved in making bridges in the 
microfibrillar component of the ECM, thus this protein family is clearly of potential interest 
in the remodeling process that weakens FM prior to rupture. There have been no previous 
reports describing fibulin family proteins in amnion. We also demonstrated that amnion 
epithelial and mesenchymal cells produced all three fibulins and their abundance was 
inhibited by TNF-, a cytokine involved in weakening of FM (Ossovskaya et al., 2004). We 
speculate that the amnion microfibrillar layer undergoes significant remodeling with the 
development of FM weak zone. 
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3.4 Stretch forces increase rupture strength of the FM rather than decreasing it 
It was previously thought that during labor, the FM weakens progressively as a result of 
repetitive stretching due to contractions. Toppozada (Toppozada et al., 1970) showed that 
the specific contraction causing rupture of membranes was rarely the most forceful 
contraction that had been experienced up to that time. They reasoned that prior contractions 
weakened the membrane so that it subsequently gave way with less force. Lavery described 
stress relaxation, creep and thinning in FM as part of their study of viscoelastic properties 
(Lavery et al., 1977, 1982). They assumed, but did not demonstrate, that membranes were 
weaker (had a lower Rupture Strength) after experiencing viscoelastic, non-recoverable 
deformation. To test this hypothesis, we collected term vaginally delivered, FM, which were 
strength tested after being cyclically stretched (Pandey et al., 2007). Rupture Strength and 
Work to rupture were determined for intact unstretched FM (control) and compared with 
topographically adjacent FM pieces which were stretched to 75 % of the Rupture Strength of 
controls, for 5, 10 or more cycles of 10 seconds each. Repeated stretching caused non-elastic 
deformation of the FM as reported by Lavery et al but the Rupture Strength after repeated 
stretching paradoxically increased rather than decreased. Stretched FM Rupture Strength 
increased 20-40% with respect to controls after 5 or 10 cycles. In contrast, Work to Rupture 
decreased. After a large number of cycles (20-30), Rupture Strength ultimately decreased. 
The number of cycles of stretch required to promote weakening of the FM was highly 
variable and may be related to the cycles that the membrane had gone through prior to 
delivery. When separated FM components were tested, amnion alone showed the same 
altered pattern of Rupture Strength and Work to Rupture after stretch cycling as the intact 
tissue - Rupture Strength initially increased while Work to Rupture decreased. 
Choriodecidua did not exhibit properties of stretch induced deformation. FM thus undergo 
deformation with stretch cycling. The initial cycles of high force stretching causes an 
increase in FM Rupture Strength, but decreased Work to Rupture (likely due to the amnion 
component alone). With continued cycling, Rupture Strength also ultimately decreased. We 
speculate that collagen fibers in FM may realign during initial stretch cycles as they do in 
stretched skin and cartilage. This may effectively strain harden the FM, increasing Rupture 
Strength and thus protecting the FM from precipitous rupture. This protective mechanism 
may fail after many cycles of stretch allowing FM to rupture at lower Rupture Strength and 
lower Work to Rupture. 
4. Preterm Premature Rupture of FM 
The precipitant causes of preterm FM weakening leading to PPROM remain uncertain. 
Limited data is available on FM physical properties in preterm patients. The studies in our 
laboratory utilizing our methodology confirm that premature FM are stronger than term 
with a significant drop-off after 37 to 38 weeks gestation (Rangaswamy et al., 2011; fig. 6.). 
Other researchers (Pressman et al., 2002; Lavery et al., 1979; Chua et al., 2009) have studied 
the effects of gestational age on FM strength and noted a statistically significant decrease in 
FM tensile strength after 39 weeks gestation which is consistent with our findings. Our 
study is the first to demonstrate heterogeneity in biomechanical properties across preterm 
FM as we have previously shown in term FM (El-Khwad et al., 2005). This mandates that a 
greater degree of remodeling and/or degradation would be necessary for preterm FM to 
rupture than occurs in term FM. Although a definitive para-cervical Weak Zone cannot 
usually be located in PPROM FM because the para-cervical region cannot be marked prior 
to delivery, a relative weak zone along the rupture tear line is generally present.  
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Fig. 6. FM rupture strength (upper panel) and work to rupture (lower panel) comparing the 
weak zone vs. strong areas across gestational groups: A decreasing trend in both rupture 
strength and work to rupture is shown from preterm to term gestation (Data are presented 
as the mean ± SD, +^* indicate p < 0.001). Reproduced with permission from Gynecol Obstet 
Fertil. 2011 ; 39(6):373-377 (Rangaswamy et.al., 2011). 
Although the mechanism of FM rupture at term or with PPROM is not well understood, we 
believe that PPROM occurs due to an abnormal early activation of the processes that 
weaken FM at term. Supportive findings of this theory are the marked upregulation of 
MMPs, pro-inflammatory cytokines and chemokines in amniotic fluid and FM in PPROM 
and chorioamnionitis (Cox et al., 1997; Maymon et al., 1999; Thomakos et al., 2010; Bryant-
Greenwood et al., 1995; Fortunato et al., 2003; Riley et al., 1999; Locksmith et al., 2001; Xu et 
al., 2002). TNF and IL-1ǃ specifically have been shown to induce apoptosis, induce MMP 9 
and increase PGE2  production in chorioamnion and cultured primary amnion cells (R.M. 
Moore et al., 2009b; Runic et al., 1998; Fortunato et al., 2001; Furuta et al., 2000; Lundin-
Schiller et al., 1991; Garcia-Lloret et al., 1996; Lockwood et al., 2008). We previously reported 
that several physiological agents and reactive oxygen species (hydrogen peroxide) induce 
apoptosis with concomitant PGE2 release in amnion derived WISH cells, primary amnion 
cells and intact amnion (Kumar et al., 2004 a, 2004 b). 
Inflammation due to an ascending bacterial infection from the female genital tract remains the 
most widely speculated cause as up to 55 percent of patients with PPROM had culture or PCR 
evidence of infection (Jones et al., 2009). Inflammatory processes at sites remote from the 
female genital tract (e.g.: periodontal infections) may also increase the levels of 
proinflammatory cytokines at the materno-fetal, interface (Offenbacher et al., 2006; Carta et al., 
2004). Decidual hemorrhage/abruption is also highly associated with PPROM (Harger et al., 
1990; Salafia et al., 1995). Additional risk factors include advanced maternal age, primiparity, 
(Ladfors et al., 2000) smoking, (Burguet et al., 2004) short cervical length (Iams et al., 1996) 
structural abnormality of chorioamniotic membranes (Stuart et al., 2005), and PPROM with 
preterm birth in a previous pregnancy (Ladfors et al., 2000; Lee et al., 2003; Shen et al., 2008). 
African American women are at higher risk of PPROM than Caucasian women (Goldenberg et 
al., 1996a), which might be due to racial differences in the regulation of promoter activity of 
pro-inflammatory cytokines and MMPs (Simhan et al., 2003; Ferrand et al., 2002). 
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Two major processes that have been associated with PPROM are inflammation (due to 
infection and other etiologies) and decidual hemorrhage/abruption. We have developed 
and utilized a unique model system to investigate FM weakening due to each of these 
etiologies and identified a pharmacological agent with potential role in preventing this 
weakening process, which will be discussed in the next two sections. 
5. Investigations to understand mechanism(s) of FM weakening and rupture 
5.1 Development of an in vitro model system to study the mechanisms of FM rupture 
There are no animal models for the study of human FM weakening and rupture. We have 
used FM strength testing equipment and methods that allow us to systematically measure 
and map human FM biomechanical properties over the entire FM surface and correlate these 
with local biochemical properties (as discussed above) in conjunction with an adaptation of 
the explant culture system developed by Fortunato and Menon (Fortunato et al., 1994) to 
produce a model system to study the process of human FM weakening (R.M. Moore et al., 
2006, 2009b, 2010; Kumar et al., 2011; Mercer et al., 2010). Full thickness FM explants are cut 
from regions of the FM distant from the Weak Zone of FM from unlabored Cesarean 
deliveries. The explants are then incubated for 2 to 4 days with agents postulated to affect 
the weakening process. Biomechanical testing is then performed and correlated with local 
induced biochemical changes in the immediately adjacent tissue. This model system is novel 
and unique in its ability to quantitatively measure FM weakening, the major parameter of 
clinical interest, as well as the associated biochemical changes. We are using this model 
system to explore the mechanisms by which FM weakening occurs as the result of two 
processes, inflammation/infection and decidual hemorrhage/abruption, which are both highly 
associated with preterm birth due to PPROM.  
5.2 Inflammation/Infection induced FM weakening 
Under normal circumstances, pregnancy is regulated by a balanced activity of anti-
inflammatory and pro-inflammatory cytokines/chemokines (Ugwumadu et al., 2002; Diehl 
et al., 2002). They play an important role in placental growth and development (Croy et al., 
2002). Progesterone may play an important role in continuation of pregnancy by promoting 
anti-inflammatory cytokines over pro-inflammatory cytokines. During the end of pregnancy 
at term, the activity of pro-inflammatory cytokines dominates resulting in the weakening 
and rupture of FM. At term, the amniotic fluid contains anti-inflammatory cytokines IL-10, 
IL-4, IL-1 receptor antagonist (Il-1RA) and transforming growth factor - (TGF-) [Jones et 
al., 1997; Dudley et al., 1996; Baergen et al., 1994; Romero et al., 1992b; A.G. Moore et al., 
2000; Heikkinen et al., 2001]. The functions of these cytokines include suppressing pro-
inflammatory cytokines (by IL-4), modulation of IL-1 mediated inflammatory effects (by IL-
1RA) and inhibition of production of pro-inflammatory cytokines and suppression of the 
activity of antigen presenting cells (by IL-10). 
The role of cytokines is not just limited to normal childbirth but also occurs in births 
(including preterm births) associated with infection. However, there are likely some 
differences (Bryant-Greenwood et al., 2007; Osman et al., 2006; Haddad et al., 2006; Beutler 
et al., 2004). The severity of inflammatory response that occurs in normal labor is relatively 
less compared to that seen in infections (Rusterholz et al., 2007). Relaxins, nuclear factor 
(NF)-kB and toll-like receptor (TLR)-2 are all part of the inflammatory cascade that result in 
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term/preterm labor or weakening and rupture of FM (Bryant-Greenwood et al., 2009; Millar 
et al., 1998; Werner et al., 2005; Hoebe et al., 2004). The amniotic fluid in normal 
uncomplicated pregnancy shows elevated pro-inflammatory cytokines (IL-1, IL-6 and 
TNF-) with increasing gestation (Opsjln et al., 1993; Romero et al., 1990b; Laham et al., 1994 
& 1996), which is further increased during labor at term (Opsjln et al., 1993; Romero et al., 
1990b; Laham et al., 1994; Cox et al., 1997; Maymon et al., 1999; Gunn et al., 1996; Romero et 
al., 1990a & 1992a). Infection during pregnancy further elevates the levels of these cytokines 
in amniotic fluid, FM and decidua (Goldenberg et al., 2000). This fact holds well even in 
preterm deliveries (compared to term) especially with infection and PPROM (Cox et al., 
1997; Maymon et al., 1999; Romero et al., 1988 & 1993). The source of these cytokines is the 
infiltrating leucocytes as demonstrated by immunolocalization studies of gestational tissues 
(Young et al., 2002). Both amniotic fluid IL-16 and IL-18 are increased with infection. IL-18 is 
a pleiotropic cytokine that plays a role in host defense against infection whereas IL-16 is 
unique, functioning as a chemoattractant, modulator of lymphocytes, monocytes, 
eosinophils and dendritic cells, and in cell cycle control (Jones et al., 2009). On the other 
hand, the anti-inflammatory cytokines also increase with term and preterm labor, the most 
marked elevation occurring in preterm delivery with infection.  
 
 
Fig. 7. TNF weakens full thickness FM. [Left] TNF-induced dose-dependent decreases in FM 
strength (A) and work to rupture (B). Incubations were for 72 h. [Right] TNF (0–100 ng/ml for 
72 h) induced increases in MMP9 protein (upper panel) and decreased TIMP3 protein (middle 
panel) in FM explants in a dose-dependent manner. TNF also induced apoptosis in FM 
explants as evidenced by cleavage of PARP1 (113 kD) into 85 kD fragments (lower panel). 
Reproduced with permission from Biol Reprod 74:29-34, 2006 (Kumar D et al., 2006). 
The tissue and cellular pathways involved in cytokine induced FM weakening are not fully 
understood. Although it has been generally assumed that collagen remodeling and 
apoptosis lead to FM weakening and rupture, this had not been directly demonstrated prior 
to our recent studies. Using our in vitro model system we have shown that inflammatory 
cytokines (TNF and IL-1ǃ) weaken full thickness FM explants in a dose dependent manner 
concomitant with biochemical changes that mimic the signature of the natural Weak Zone 
(Fig. 7.) Cytokines act on FM in a complex manner. As the amnion is the strongest 
component of the FM, it must be significantly weakened in any mechanistic schema leading 
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to rupture (Arikat et al., 2006). Our published data show that cytokines do not weaken the 
isolated amnion, but readily weaken amnion when it is adherent to the choriodecidua as 
part of the full thickness FM (Kumar et al., 2011) [Fig. 8.]. In contrast, conditioned media 
produced by incubating isolated choriodecidua with cytokines readily weaken the amnion. 
It is thus clear that a critical cytokine target for FM weakening is in the choriodecidua, 
where one or more soluble products are produced which are necessary for TNF or IL-1ǃ 
induced weakening of the amnion. 
 
       
Fig. 8. TNF and IL-1ǃ cannot weaken isolated amnion directly: Experiment description [left] 
and results [right]. Isolated amnion when incubated with cytokines (center group of results) 
showed no decrease in strength and minimal changes in MMP9, TIMP3 and cleaved PARP. 
Amnion exposed to conditioned media from choriodecidua incubated with cytokines 
showed weakening and biochemical changes (right group of results). Control study results 
show amnion weakening with intact FM stimulation (left group of results). Reproduced 
with permission from Placenta 32(3):206-213, 2011 (Kumar D et al., 2011).  
5.3 Decidual hemorrhage/abruption induced FM weakening 
Thrombin may be produced in FM by decidual hemorrhage/abruption and activation of the 
extrinsic coagulation cascade. Decidual cells have been shown to have abundant tissue 
factor thus facilitating the production of Thrombin after hemorrhage (Lockwood et al., 1993 
& 2001). PPROM patients have increased tissue factor (Erez et al., 2008). Thrombin is known 
to have many actions not related to coagulation. Thrombin can act directly on the 
extracellular matrix (ECM) by converting MMPs 1, 2, 3 and 9 from zymogen to active forms 
(Fang et al., 2006; Lafleur et al., 2001). Alternatively, it can act indirectly, through cells, by 
activating Protease Activated Receptors (PAR) (Hollenberg et al., 2005; Ossovskaya et al., 
2004) and thereby inducing MMPs and other proteins, which may remodel the ECM. 
Thrombin has been shown to induce MMP9 in monocytes (Chi-Jen Chang et al., 2009), oral 
squamous cell carcinoma (Liu et al., 2001), human dermal fibroblast (Wang et al., 2007) and 
mesangial cells (Liu et al., 2000), microvascular endothelial cells from human brain (Kolev et 
al., 2003) and rabbit aortic smooth muscle cells (Fabunmi et al., 1996). Four PARs (1 – 4) have 
been described but none have yet been reported in FM. PARs are activated by the 
proteolytic activity of thrombin and other serine proteases (thrombin acts on PARs 1, 3 and 
4 and trypsin acts upon PAR 2). These enzymes cleave the N-terminus of the receptor, 
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which thereafter permanently acts as a tethered ligand causing a physiological response. 
Synthetic PAR activating peptides (PAR-AP) composed of the initial amino acid string of the 
new N-terminus generated when thrombin cleaves PAR, can activate their specific PAR 
independent of thrombin or receptor cleavage (Refer table below).  
 
Receptor Activating Peptide Control Peptide 
PAR 1 TFLLR-NH2 FTLLR-NH2 
PAR 2 SLIGRL-NH2; 2furoyl-LIGRLO-NH2 LSIGRL-NH2; 2furoyl-OLRGIL-NH2 
PAR 3 NOT activated by PAR-APs --------- 
PAR 4 AYPGKF-NH2 YAPGKF-NH2 
Table 1.  
These PAR-APs have been used extensively as pharmacological tools for probing the effects 
of specific PAR activation in cells and tissues independent of the other effects of thrombin. 
PAR-APs are commercially available for most of the PAR receptors (table). Inactive control 
peptides with a reversal of two AA’s are also available (Ramachandran & Hollenberg, 2008). 
We have evidence that the PAR-AP for PAR 1 weakens isolated amnion (fig 10 – sub figure 
2). The PAR receptors act through G-proteins families including: I (cAMP inhibitory), 12/13 
(Raf/Ras activation) or q (calcium signaling) which in turn activate a number of signaling 
cascades including MAP kinases, Akt/PKB, P13 kinase and NFkB (101).  
Our recent report demonstrates that Thrombin weakens full thickness FM in a dose 
dependent fashion in our model system (Moore et al., 2010, fig. 9). We have also reported 
that Thrombin increases both the zymogen and active forms of MMP-9 and MMP-3 in the 
amnion (Furuta et al., 2000). The latter is particularly interesting as MMP-3 can activate 
other MMPs, especially MMP-2, which is prevalent in the amnion but is not further induced 
by either cytokines or Thrombin.  
 
 
Fig. 9. Thrombin weakens full thickness FM. [Left] Thrombin-induced dose-dependent 
decreases in FM strength, stiffness and work to rupture. All incubations were for 48 h.  
(* P < 0.01). [Right] Thrombin induced increases in MMP3 protein (upper panel) and MMP9 
protein (lower panel) in FM explants in a dose-dependent manner. (Reproduced with 
permission from Moore et al. Placenta 2010.) 
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In further work we have found that, unlike cytokines, thrombin can directly weaken the 
isolated amnion. The critical targets for thrombin are thus in amnion rather than the 
choriodecidua. [Fig. 10 – subfigures 1, 3 & 4] 
 
          
Subfigure 1                                       Subfigure 2 
 
      
Subfigure 3                                           Subfigure 4 
Fig. 10. [Top Left] Thrombin weakens isolated amnion. (* p < .01 vs. control), 
[Top Right] PAR 1 (1 uM) activating peptide (TRAP) weakens isolated amnion (p<.001), 
[Below] Thrombin increases MMP9, decreases TIMP3 and increases PARP cleavage in 
isolated amnion (all *p<.001). . (Reproduced with permission from Kumar et al. Placenta 
2011.) 
5.4 Inflammatory cytokines and thrombin have different mechanisms of FM 
weakening 
As the amnion is the strongest component of the FM, it must be significantly weakened in 
any mechanistic schema leading to rupture. For this reason agents that weaken FM were 
tested for their effect upon isolated amnion membranes. Cytokines (TNF or IL-1ǃ) do not 
weaken the isolated amnion, but readily weaken amnion when it is adherent to the 
choriodecidua as part of the full thickness FM. In contrast, conditioned media produced by 
incubating isolated choriodecidua with these cytokines readily weaken the amnion. It is 
thus clear that a critical cytokine target for FM weakening is in the choriodecidua, where 
one or more soluble products are produced which are necessary for TNF or IL-1ǃ induced 
weakening of the amnion (Kumar et al., 2011). On the other hand Thrombin can directly 
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weaken the isolated amnion. The critical targets for Thrombin induced FM weakening are 
thus in amnion rather than the choriodecidua (Kumar et al., 2011). 
6. Investigations targeting the potential prevention of FM weakening and 
rupture 
6.1 Tissue repair and prevention of weakness 
A major objective of research into the physiology of FM rupture is the development of 
possible strategies for membrane repair or prevention of premature weakening. Studies of 
tissue repair after physically induced injury have been limited. Artal (Artal et al., 1976) 
demonstrated that membranes placed in pseudo-amniotic fluid become weaker over 24 
hours but remain unchanged if a mixture of pharmacological enzyme inhibitors is included. 
The tissue surrounding a stab wound in FM has been shown to be viable for up to 12 days 
but the wound remained unhealed (Devlieger et al., 2000a). Millar et al (2003) demonstrated 
increased growth of amnion epithelium with IGF-II. Using a rabbit model, Devlieger et al 
(2000b & 2003) have shown some success in incorporating plugs into iatrogenic ruptured 
sites. Growth factors, TGFǃ and FGFǃ, which normally accelerate repair in other tissues, 
were shown by the same group to improve the rate of FM repair, although the concomitant 
increased inflammatory response was of concern because of its possible exacerbation of 
events leading to premature delivery (Devlieger et al., 2003). FM injured in vitro, thus seem 
to have minimal tendency for self-repair. Clinical studies of FM sealants and sealing 
techniques have been undertaken in hopes of restoring amniotic fluid volume and averting 
the risks of prolonged oligohydramnios after extremely early PPROM. An in vitro study has 
revealed that platelets aggregate with exposure to amnion, but not to chorion or amniotic 
fluid, and that platelet adhesion and activation occur with exposure to the connective tissues 
underlying amnion and chorion but not amniotic epithelium (Louis-Sylvestre et al., 1998). 
Similarly, Harmali et al have demonstrated improved membrane tensile strength (Rupture 
Tension, Strain to Rupture, and Work to Rupture) with iatrogenic defects after application of 
a fibrin sealant, but that the membrane strength remains less than that of unruptured 
membrane segments (Harmanli et al., 1998). Fibrin/thrombin based sealants, but not platelet 
infusions, have been shown to cause temporary cessation of leakage (Reddy et al., 2001). 
Regarding non-biologic barriers, O’Brien et al (2001) evaluated gelatin sponge (Gelfoam, 
TM) applied over larger defects and found it to effectively dam linear defects of up to 7 mm 
in length, but not complex defects. The ability to fuse (“weld”) FM with Nd: YAG Laser 
applied to polytetrafluoroethylene has also been demonstrated in-vitro, though the ability of 
such intervention to seal a membrane defect has not (Mendoza et al., 1999). 
There has been some success in the treatment of iatrogenic membrane rupture. In 1999, 
Quintero and co-workers (Quintero et al., 1998 & 1999) demonstrated successful membrane 
sealing for persistent oligohydramnios after amniocentesis and fetoscopy, using intra-
amniotic injection of platelets and cryoprecipitate (“amniopatch”) through a 22-gauge 
needle. Successful membrane sealing has been achieved with intrauterine injection of gelatin 
sponge (O’Brien et al., 2002). Sciscione and co-workers (2001) were able to achieve cessation 
of leakage and restoration of normal amniotic fluid volume in some women with 
intracervical instillation of fibrin sealants. However, the need for concurrent cervical 
cerclage placement to decrease fluid leakage has been described (Baumgarten & Moser, 
1986). Young and colleagues (Young et al., 2000, 2004a) demonstrated successful 
endoscopically guided sealing of an iatrogenic membrane defect using maternal platelets 
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and fibrinogen/thrombin and subsequently demonstrated success with fibrin glue and 
powdered collagen slurry applied to puncture sites. While these studies, and other small 
case series, have raised the potential that membrane sealing can be performed effectively 
when the defect occurs in otherwise normal FM, further study regarding the optimal timing 
and method of intervention after iatrogenic PROM is needed.  
Ultimately, because of the presence of antecedent membrane degradation and sub-clinical 
inflammation in the fetal membranes, membrane sealing may not be appropriate for those 
with spontaneous membrane rupture. It is not surprising that membranes that have 
ruptured as the result of having undergone extensive extracellular remodeling and cellular 
apoptosis may not readily reverse their physiological direction and repair themselves. 
Further study regarding the maternal/fetal risks and fetal benefits of invasive interventions 
for membrane rupture remote from term are warranted before such practices are 
incorporated into clinical practice. A detailed understanding of the process of physiological 
and pathological fetal membrane weakening may allow appropriate early intervention. Our 
models of in vitro tissue weakening with biochemical agents and stretch may prove useful 
in evaluating potential repair strategies. 
6.2 Prevention of weakening and rupture – Identification of at risk pregnancies 
If the potential for FM repair after rupture is limited, perhaps premature weakening of the 
fetal membranes can be prevented. To be medically and ethically acceptable, any procedure 
done on pregnant women to prevent possible FM weakening must be either totally 
innocuous or highly targeted toward women at significant risk for PPROM. In order to 
target women at risk they must first be reliably identified.  
Spontaneous preterm birth due to preterm labor and PROM is associated with a variety of 
clinical characteristics and also with abnormal ancillary test findings (e.g. short cervix on 
transvaginal ultrasound, a positive cervicovaginal fetal-fibronectin screen) (Rangaswamy et 
al., 2011; Iams et al., 1996; Mercer et al., 1996; Goldenberg et al., 1996b). However, such 
evaluations are neither sensitive nor specific when applied to asymptomatic women, and 
there is significant overlap in the characteristics of women who ultimately deliver due to 
preterm labor and PROM (Mercer et al., 2000). As such, it remains difficult to identify those 
who will develop PROM before the fact. Recently, several groups have demonstrated that 
African Americans, a group with a high incidence of PPROM with early delivery, have a 
higher incidence of certain more active polymorphisms of MMPs and pro-inflammatory 
cytokines (Ferrand et al., 2002; Fujimoto et al., 2002; Hernandez-Guerrero et al., 2003; 
Roberts et al., 1999). It is possible that a combination of genes and historical factors could 
eventually lead to prediction of risk of PPROM with adequate certainty that procedures 
designed to prevent FM rupture that carry some inherent  risk would be justifiable.  
In the presence of minimal or no identified risk, administration of vitamin C alone or in 
combination with vitamin E has been suggested for the prevention of PPROM, mainly for 
their antioxidant effect (Siega-Riz et al., 2003). However, there are concerns regarding the 
use of vitamin C as it can increase or decrease apoptosis (Orzechowski et al., 2002) 
depending on the cell system, dose, and co-effectors present. We have shown that vitamin C 
does not inhibit, and may exacerbate H2O2 induced apoptosis in amnion-derived WISH 
cells, amnion cell cultures, and amnion membrane explants (Kumar et al., 2004a, 2004b). In 
vivo studies have also shown mixed results with use of vitamin C. Although a single clinical 
trial of oral vitamin C demonstrated a decrease in PROM but not premature delivery, three 
much larger studies showed increased PROM and PPROM in the vitamin-supplemented 
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groups (Spinnato et al., 2008; Hauth et al., 2010; Xu et al., 2010). Warnings were issued in 
these publications about use of vitamins C/E, at least at the doses utilized. Using our in vitro 
model of TNF-ǂ-induced FM weakening, we have demonstrated that vitamin C 
preincubation does not prevent TNF-ǂ induced FM weakness. In fact, high doses of vitamin 
C actually increase MMP-9 activity and weaken the FM. 
6.3 Alpha-Lipoic Acid (LA) inhibits cytokine and thrombin induced weakening 
In contrast, we have shown that Lipoic acid, a naturally occurring dietary supplement 
[routinely used as part of prophylaxis for diabetic neuropathy (Ziegler et al., 2009)], with 
anti-oxidant and NFkB inhibitory properties prevented TNF-ǂ induced FM weakening and 
also prevented concomitant TNF-ǂ induced increases in MMP-9 and PGE2 (Fig. 11.) [R.M. 
Moore et al, 2009]. The mechanism of Lipoic acid action is unclear but this effect on FM is 
not isolated. It has been shown to inhibit TNF- ǂ induced NF-κB transcriptional activity and 
MMP-9 expression in vascular smooth muscle cells, and attenuate LPS-induced NF-κB: 
DNA-binding in monocytes by activating the PI3K/AKT pathway (Kim et al., 2007; Zhang 
et al., 2007). It also metabolically regenerates glutathione and other antioxidants (Bilska & 
Wlodek et al., 2005). We have also demonstrated that LA inhibits FM weakening by 
Thrombin and inhibits Thrombin induced weakening of the isolated amnion (Kumar et al., 
2011). As Lipoic acid inhibits both cytokine and thrombin induced FM weakening and 
remodeling, it is a promising candidate for possible clinical use to prevent PPROM. LA has 
been investigated in dozens of clinical trials (41 trials are now listed on clinicaltrials.gov) 
with no adverse effects reported. Unfortunately, all of the trials excluded pregnant women 
(Clinicaltrials.gov). There have also been promising toxicity studies in pregnant rats 
(Shirpoor A et al., 2008). A trial of LA in pregnant women at risk for PPROM awaits more 
definitive information of its mechanism of action in the prevention of FM weakening in 
addition to safety data.  
 
  
Fig. 11. Lipoic Acid inhibits TNF and Thrombin induced weakening and biochemical 
changes: [Left] TNF (50 ng/ml) induced weakening, increases in MMP9 and increases in 
PGE2 are inhibited by Lipoic Acid (0.5 mM); [Middle] Thrombin (10 U/ml) induced changes 
in biomechanics are inhibited by lipoic acid (.25 mM); [Right] Thrombin (10 U/ml) induced 
increases in MMP9 zymogen and active forms are inhibited by Lipoic Acid (.25 mM). 
Reproduced from Moore et al. Biol Reprod 80:781-87, 2009 and Placenta 31:886-892, 2010 
with permission. 
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7. Conclusions 
It had been previously thought that the mechanical force due to uterine contraction during 
labor weakens the FM. This theory has been negated by the clinical fact that the FM rupture 
prior to the onset of contractions and by our finding that the force required to rupture the 
membranes is increased rather than decreased by cyclical mechanical stretching of FM in 
vitro. We have demonstrated that a weak zone develops in the FM overlying the cervix at 
the end of gestation. This weak zone is associated with collagen remodeling and apoptosis 
as evidenced by elevated MMP-9, decreased TIMP-3 and elevated PARP cleavage. Even 
though the process of weakening in term FM has been described, detailed molecular 
mechanisms and the initiating signals have yet to be unraveled. Our in vitro model system 
has facilitated demonstration that the weakening effect of cytokines (TNF-ǂ and IL-1ǃ) and 
thrombin on FM results in collagen remodeling and apoptosis, similar to that observed in 
term FM delivered by unlabored cesarean and labored vaginal deliveries. Lipoic acid has 
been shown to inhibit the weakening effect of both these agents in vitro, suggesting that it 
could be a promising drug in the prevention of PPROM. However, studies are required to 
demonstrate its safety and efficacy in pregnant women. 
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